Teva ’s ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment
Teva Pharmaceutical, based in Israel, landed the first FDA approval for a digital inhaler with built-in sensors. The ProAir Digihaler (albuterol sulfate 117 mcg) Inhalation Powder is indicated for people suffering from asthma & COPD as a way of...
Source: Medgadget - Category: Medical Devices Authors: Editors Tags: Cardiology Medicine Source Type: blogs
More News: Albuterol | Allergy | Allergy & Immunology | Asthma | Cardiology | Chronic Obstructive Pulmonary | Heart | Israel Health | Medical Devices | Middle East Health | Proair HFA | Ventolin